XML 63 R33.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
Schedule of provision for income taxes

Provision for income taxes consists of the following:

 

 

 

For the Year Ended December 31,

 

 

 

2022

 

 

2021

 

 

 

(in thousands)

 

Federal tax provision:

 

 

 

 

 

 

Current

 

$

698

 

 

$

 

Deferred

 

 

 

 

 

 

Total federal tax provision

 

 

698

 

 

 

 

State tax provision:

 

 

 

 

 

 

Current

 

 

17

 

 

 

 

Deferred

 

 

 

 

 

 

Total state tax provision

 

 

17

 

 

 

 

Total tax provision

 

$

715

 

 

$

 

Schedule of Reconciliation between U.S. Federal Statutory Tax Rate and Effective Tax Rate

A reconciliation between the U.S. federal statutory tax and the Company’s tax provision is summarized below. The Company has changed the presentation of its rate reconciliation from percentages to dollar amounts in the current year.

 

 

 

For the Year Ended December 31,

 

 

 

2022

 

 

2021

 

 

 

(in thousands)

 

Federal statutory tax

 

$

(901

)

 

$

(20,111

)

Tax credits

 

 

(13,955

)

 

 

(8,940

)

State taxes, net of federal tax benefit

 

 

(2,994

)

 

 

(8,240

)

Non-deductible expenses

 

 

875

 

 

 

1,331

 

Other

 

 

1,410

 

 

 

(2,401

)

Change in valuation allowance

 

 

16,280

 

 

 

38,361

 

Tax provision

 

$

715

 

 

$

 

Schedule of Deferred Tax Assets and Liabilities

The principal components of the Company’s deferred tax assets and liabilities consist of the following:

 

 

 

December 31,

 

 

 

2022

 

 

2021

 

 

 

(in thousands)

 

Deferred tax assets:

 

 

 

 

 

 

Net operating losses

 

$

76,735

 

 

$

100,417

 

R&D credits

 

 

66,761

 

 

 

51,705

 

Equity compensation

 

 

7,888

 

 

 

6,919

 

Operating lease liabilities

 

 

8,003

 

 

 

6,520

 

Accrued expense and other

 

 

1,479

 

 

 

2,072

 

Deferred revenue

 

 

314

 

 

 

1,189

 

Capitalized R&D costs

 

 

24,477

 

 

 

868

 

Total deferred tax assets

 

 

185,657

 

 

 

169,690

 

Deferred tax liabilities:

 

 

 

 

 

 

Right-of-use assets

 

 

(5,583

)

 

 

(4,252

)

Depreciation

 

 

(171

)

 

 

(1,541

)

Other

 

 

(251

)

 

 

(503

)

Total deferred tax liabilities

 

 

(6,005

)

 

 

(6,296

)

Valuation allowance

 

 

(179,652

)

 

 

(163,394

)

Net deferred taxes

 

$

 

 

$

 

Schedule of valuance allowance A roll forward of the valuation allowance is as follows:

 

 

Valuation

 

 

 

Allowance

 

 

 

(in thousands)

 

Balance at December 31, 2021

 

$

(163,394

)

Utilization of net operating losses against taxable income

 

 

23,654

 

Increase in net deferred taxes

 

 

(39,912

)

Balance at December 31, 2022

 

$

(179,652

)